Publication date: Oct 23, 2024
Health inequalities represent a major challenge in contemporary medicine, with some attributed to racial biases. Recently, in the United States, a call to combat discrimination in the field of health has resonated, particularly in the context of the COVID-19 crisis, in which minorities have been disproportionately affected. These calls echo recommendations from the Institute of Medicine dating back to 2001, urging the fight against inequalities in access to health care. In France, inequalities based on presumed origin persist, yet medical education on these issues is virtually nonexistent. We conducted a scoping review literature review in accordance with the JBI recommendations for scoping review writing and applied the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) checklist to explore existing conceptual and educational data on racial biases in medicine. The inclusion criteria were interventional studies or evaluations of existing educational programs in medical training addressing the fight against racial biases in clinical settings published in French or English between 2003 and 2023. Six databases were systematically consulted. Out of 748 initial studies, 28 were included in our study. The median number of participants in the studies was low, interventions were diverse, and participants were generally well received, most of whom were self-selected. No study has evaluated the clinical impact of these interventions. The highlighted concepts included levels of racism, cultural competence, cultural humility, and critical race theory. The authors most frequently referred to institutionalized racism, demonstrating the systemic nature of these issues. At an individual level, implicit and unconscious biases were most often emphasized. It appears that the concept of “race” is a sociopolitical construct without supporting biological determinants. Humility is central to this field of study, as it encourages questioning of individual or collective medical practices. In France, the context, including the prohibition of ethnic statistics, may hinder the objectification of discrimination. Immersion and virtual patient scenarios emerged as potential solutions for evaluating the clinical impact of interventions. A more horizontal medical pedagogy seems better suited to teach these sensitive issues.
Open Access PDF
Concepts | Keywords |
---|---|
Dating | COVID-19 |
France | Education, Medical |
Medicine | France |
Race | Health inequities |
Racism | Healthcare Disparities |
Humans | |
Implicit bias | |
Medical education | |
Racism | |
Racism | |
SARS-CoV-2 |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | Health inequalities |
disease | MESH | COVID-19 |
disease | MESH | access to health care |
drug | DRUGBANK | Tropicamide |
pathway | REACTOME | Reproduction |
drug | DRUGBANK | Coenzyme M |
drug | DRUGBANK | Diethylstilbestrol |
drug | DRUGBANK | L-Citrulline |
disease | IDO | history |
disease | MESH | syphilis |
disease | MESH | emergency |
disease | MESH | syndrome |
drug | DRUGBANK | Methionine |
drug | DRUGBANK | Indoleacetic acid |
disease | IDO | process |
disease | IDO | country |
drug | DRUGBANK | Methylergometrine |
disease | IDO | homo sapiens |
drug | DRUGBANK | Creatinine |
disease | MESH | lifestyle |
disease | IDO | quality |
drug | DRUGBANK | Ethionamide |
drug | DRUGBANK | Fenamole |
drug | DRUGBANK | Aspartame |
disease | IDO | production |
drug | DRUGBANK | Cysteamine |
drug | DRUGBANK | Trestolone |
disease | IDO | intervention |
disease | MESH | uncertainty |
disease | IDO | susceptibility |
drug | DRUGBANK | Trihexyphenidyl |
drug | DRUGBANK | Profenamine |
drug | DRUGBANK | Ilex paraguariensis leaf |
drug | DRUGBANK | Gold |
drug | DRUGBANK | Roxithromycin |
disease | MESH | violence |
drug | DRUGBANK | Spinosad |